NxStage Medical (NXTM) Tops Q4 EPS by 2c

NxStage Medical (NASDAQ: NXTM) reported Q4 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.9 million versus the consensus estimate of $75.75 million.

For earnings history and earnings-related data on NxStage Medical (NXTM) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Robinhood shares climb on summit momentum and analyst support
• LTC Properties (LTC) PT Raised to $52 at RBC Capital